Division of Cardiovascular Surgery, Pronto Socorro Cardiológico de Pernambuco - PROCAPE, University of Pernambuco, Pernambuco, Brazil.
Division of Cardiac Surgery, Escola Paulista de Medicina - UNIFESP, São Paulo, Brazil.
Trends Cardiovasc Med. 2021 Oct;31(7):435-445. doi: 10.1016/j.tcm.2020.10.002. Epub 2020 Oct 13.
Aortic stenosis (AS) remains one of the most common valvular heart diseases, with enormous impact on patient survival. Over the past years, transcatheter aortic valve implantation (TAVI) has become a reality worldwide, offering a less invasive method to treat AS. Apart from the classical indications for aortic valve disease, recent studies tried to address unanswered questions for TAVI - asymptomatic severe AS, bicuspid aortic valves and moderate AS in patients with heart failure. This review discusses the rationale of those possible indications, pitfalls and current evidence in the medical literature.
主动脉瓣狭窄(AS)仍然是最常见的心脏瓣膜疾病之一,对患者的生存有巨大影响。在过去的几年中,经导管主动脉瓣植入术(TAVI)已在全球范围内成为现实,为治疗 AS 提供了一种侵入性较小的方法。除了主动脉瓣疾病的经典适应证外,最近的研究还试图解决 TAVI 的一些未解决的问题——无症状重度 AS、二叶式主动脉瓣和心力衰竭患者的中度 AS。这篇综述讨论了这些可能适应证的基本原理、陷阱和目前的医学文献证据。